Tyra C. Zetterstrom
Leicester, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Effects of Methylphenidate on the Dopamine Transporter and Beyond.
Journal: Current topics in behavioral neurosciences
Published: May 04, 2022
Effect of antidepressant drugs on the brain sphingolipid system.
Journal: Journal of psychopharmacology (Oxford, England)
Published: May 15, 2020
Chronic methylphenidate preferentially alters catecholamine protein targets in the parietal cortex and ventral striatum.
Journal: Neurochemistry international
Published: November 22, 2018
Methylphenidate alters monoaminergic and metabolic pathways in the cerebellum of adolescent rats.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: July 07, 2017
Chronic methylphenidate regulates genes and proteins mediating neuroplasticity in the juvenile rat brain.
Journal: Neuroscience letters
Published: April 13, 2017
1H NMR-based metabolomics reveals neurochemical alterations in the brain of adolescent rats following acute methylphenidate administration.
Journal: Neurochemistry international
Published: January 03, 2017
Tyrosine-free amino acid mixtures reduce physiologically-evoked release of dopamine in a selective and activity-dependent manner.
Journal: Journal of psychopharmacology (Oxford, England)
Published: October 11, 2013
The role of 5-hydroxytryptamine receptor subtypes in the regulation of brain-derived neurotrophic factor gene expression.
Journal: The Journal of pharmacy and pharmacology
Published: May 28, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026